Riccardo Lobefaro
Brindisi, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Event-Free Survival After Stereotactic Body Radiation Therapy for Oligoprogressive Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: September 28, 2025
Real world feasibility of combining pembrolizumab with radiotherapy in early triple negative breast cancer.
Journal: Discover oncology
Published: February 02, 2025
Early downmodulation of tumor glycolysis predicts response to fasting-mimicking diet in triple-negative breast cancer patients.
Journal: Cell metabolism
Published: July 24, 2024
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer.
Journal: Journal of the National Cancer Institute
Published: February 13, 2024
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 03, 2023
Adding fasting-mimicking diet to first-line carboplatin-based chemotherapy is associated with better overall survival in advanced triple-negative breast cancer patients: A subanalysis of the NCT03340935 trial.
Journal: International journal of cancer
Published: June 18, 2023
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors.
Journal: Therapeutic advances in medical oncology
Published: April 10, 2023
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.
Journal: NPJ breast cancer
Published: December 16, 2022
The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis.
Journal: Therapeutic advances in medical oncology
Published: December 05, 2022
PillarX: A Microfluidic Device to Profile Circulating Tumor Cell Clusters Based on Geometry, Deformability, and Epithelial State.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: December 01, 2022
Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: Different biological and clinical entities with potentially diverse therapeutic opportunities.
Journal: Critical reviews in oncology/hematology
Published: September 15, 2022
Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison.
Journal: Clinical breast cancer
Published: July 22, 2022
Last Updated: 09/26/2026